NEUROLOGY 2005;65:448-450
© 2005 American Academy of Neurology
Brief Communications
The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
T. A. Rupprecht, MD,
H. W. Pfister, MD,
B. Angele,
S. Kastenbauer, MD,
B. Wilske, MD and
U. Koedel, MD
From the Departments of Neurology (Drs. Rupprecht, Pfister, Kastenbauer, Koedel, and B. Angele) and Microbiology (Dr. Wilske), Ludwig-Maximilians University, Munich, Germany.
Address correspondence and reprint requests to Dr. Hans-Walter Pfister, Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians University, Marchioninistr. 15, D-81377 Munich, Germany; e-mail: hans-walter.pfister{at}med.uni-muenchen.de
Using protein expression profiling, the authors identified an upregulation of the chemokine B lymphocyte chemoattractant (BLC) in the CSF of patients with neuroborreliosis but not in patients with noninflammatory and various other inflammatory neurologic diseases. This upregulation was confirmed by ELISA, showing increased BLC levels in every neuroborreliosis patient while being undetectable in patients with noninflammatory neurologic diseases. These results point to BLC as a putative additional diagnostic marker for neuroborreliosis.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the August 9 issue to find the link for this article.
Editorial, see page 351
Disclosure: The authors report no conflicts of interest.
Received July 25, 2004. Accepted in final form April 18, 2005.
Related Articles
-
August 9 Highlights
Neurology 2005 65: 342-343.
[Full Text]
[PDF]
-
Sublime diagnosis of Lyme neuroborreliosis
- Benjamin M. Segal and Eric L. Logigian
Neurology 2005 65: 351-352.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
F. Sellebjerg, L. Bornsen, M. Khademi, M. Krakauer, T. Olsson, J. L. Frederiksen, and P. S. Sorensen
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
Neurology,
December 8, 2009;
73(23):
2003 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D Festa, K. Hankiewicz, S. Kim, J. Skurnick, L. J Wolansky, S. D Cook, and D. Cadavid
Serum levels of CXCL13 are elevated in active multiple sclerosis
Multiple Sclerosis,
November 1, 2009;
15(11):
1271 - 1279.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ramesh, J. T. Borda, J. Dufour, D. Kaushal, R. Ramamoorthy, A. A. Lackner, and M. T. Philipp
Interaction of the Lyme Disease Spirochete Borrelia burgdorferi with Brain Parenchyma Elicits Inflammatory Mediators from Glial Cells as Well as Glial and Neuronal Apoptosis
Am. J. Pathol.,
November 1, 2008;
173(5):
1415 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. F. Bernardino, T. A. Myers, X. Alvarez, A. Hasegawa, and M. T. Philipp
Toll-Like Receptors: Insights into Their Possible Role in the Pathogenesis of Lyme Neuroborreliosis
Infect. Immun.,
October 1, 2008;
76(10):
4385 - 4395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wang, M. M. Petzke, R. Iyer, H. Wu, and I. Schwartz
Pattern of Proinflammatory Cytokine Induction in RAW264.7 Mouse Macrophages Is Identical for Virulent and Attenuated Borrelia burgdorferi
J. Immunol.,
June 15, 2008;
180(12):
8306 - 8315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Burkle, M. Niedermeier, A. Schmitt-Graff, W. G. Wierda, M. J. Keating, and J. A. Burger
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia
Blood,
November 1, 2007;
110(9):
3316 - 3325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Rupprecht, C. J. Kirschning, B. Popp, S. Kastenbauer, V. Fingerle, H.-W. Pfister, and U. Koedel
Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2
Infect. Immun.,
September 1, 2007;
75(9):
4351 - 4356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Mullegger, T. K. Means, J. J. Shin, M. Lee, K. L. Jones, L. J. Glickstein, A. D. Luster, and A. C. Steere
Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in Lymphocytoma
Infect. Immun.,
September 1, 2007;
75(9):
4621 - 4628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Greer, P. W. Schaefer, S. R. Plotkin, R. P. Hasserjian, and A. C. Steere
Case 11-2007 -- A 59-Year-Old Man with Neck Pain, Weakness in the Arms, and Cranial-Nerve Palsies
N. Engl. J. Med.,
April 12, 2007;
356(15):
1561 - 1570.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Lunemann, H. Gelderblom, M. Sospedra, J. A. Quandt, C. Pinilla, A. Marques, and R. Martin
Cerebrospinal Fluid-Infiltrating CD4+ T Cells Recognize Borrelia burgdorferi Lysine-Enriched Protein Domains and Central Nervous System Autoantigens in Early Lyme Encephalitis
Infect. Immun.,
January 1, 2007;
75(1):
243 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gelderblom, J. Schmidt, D. Londono, Y. Bai, J. Quandt, R. Hornung, A. Marques, R. Martin, and D. Cadavid
Role of Interleukin 10 during Persistent Infection with the Relapsing Fever Spirochete Borrelia turicatae
Am. J. Pathol.,
January 1, 2007;
170(1):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisakk, R. M. Ransohoff, M. Hofbauer, C. Farina, T. Derfuss, C. Hartle, et al.
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Brain,
January 1, 2006;
129(1):
200 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Segal and E. L. Logigian
Sublime diagnosis of Lyme neuroborreliosis
Neurology,
August 9, 2005;
65(3):
351 - 352.
[Full Text]
[PDF]
|
 |
|
|